Massive hemobilia in a cirrhosis patient after percutaneous liver biopsy

Morbidity after percutaneous liver biopsy.

The safety of percutaneous liver biopsy with a 1.2 mm Menghini needle in infants aged one year or less was investigated. One hundred and eighty four procedures performed from 1975 to 1985 were reviewed. There were no deaths or major complications within 48 hours associated with the procedure. In five instances specific complications occurred: a drop in haemoglobin concentration (three), transie...

Hemoperitoneum after percutaneous liver biopsy

Percutaneous liver biopsy (PLB) is an in or out-patient procedure diffused in most hospitals. A particularely elevate number of biopsies in our area depends on endemic infection by hepatitis B and C viruses. Nowadays it is a very safe procedure, and the actual risk of bleeding is estimated to range between 0.04 and 0.16% in nonmalignant disease 1. Major bleeding generally requires a prompt surg...

Hemobilia and Melena After Liver Biopsy: A Case Report and Review of Literature

Liver biopsy is the gold standard for assessment of hepatic fibrosis although it is associated with many complications. We reported a 28-year-old chronic HCV patient who developed gall bladder hematoma with hemobilia and melena after liver biopsy. The hematoma resolved with conservative management.

role of percutaneous liver biopsy

Liver biopsy in the diagnosis of cirrhosis.